These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 15973843)
1. Hypersensitivity reactions to oxaliplatin: what nurses need to know. Bonosky K; Miller R Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843 [TBL] [Abstract][Full Text] [Related]
2. Management of allergic reactions to oxaliplatin in colorectal cancer patients. Suenaga M; Mizunuma N; Shinozaki E; Matsusaka S; Chin K; Muto T; Konishi F; Hatake K J Support Oncol; 2008; 6(8):373-8. PubMed ID: 19149322 [TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol. Gammon D; Bhargava P; McCormick MJ Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639 [TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity reactions to oxaliplatin in two asian patients. Ng CV Ann Pharmacother; 2005 Jun; 39(6):1114-8. PubMed ID: 15886290 [TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol. Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272 [TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management. Hewitt MR; Sun W Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166 [TBL] [Abstract][Full Text] [Related]
8. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer. Nozawa H; Muto Y; Yamada Y Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of hypersensitivity reactions caused by oxaliplatin. Herrero T; Tornero P; Infante S; Fuentes V; Sánchez MN; De Barrio M; Baeza ML J Investig Allergol Clin Immunol; 2006; 16(5):327-30. PubMed ID: 17039675 [TBL] [Abstract][Full Text] [Related]
11. Clinical Features of Oxaliplatin Induced Hypersensitivity Reactions and Therapeutic Approaches. Bano N; Najam R; Qazi F; Mateen A Asian Pac J Cancer Prev; 2016; 17(4):1637-41. PubMed ID: 27221832 [TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity and idiosyncratic reactions to oxaliplatin. Thomas RR; Quinn MG; Schuler B; Grem JL Cancer; 2003 May; 97(9):2301-7. PubMed ID: 12712487 [TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity reactions associated with oxaliplatin and their clinical management. Toki MI; Saif MW; Syrigos KN Expert Opin Drug Saf; 2014 Nov; 13(11):1545-54. PubMed ID: 25307143 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents. Lee C; Gianos M; Klaustermeyer WB Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of reintroducing oxaliplatin to patients with colorectal cancer after mild hypersensitivity reactions. Park SJ; Lee KY; Park WS; Min SY Oncology; 2013; 85(6):323-7. PubMed ID: 24247529 [TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX. Mori Y; Nishimura T; Kitano T; Yoshimura K; Matsumoto S; Kanai M; Hazama M; Ishiguro H; Nagayama S; Yanagihara K; Teramukai S; Chiba T; Sakai Y; Fukushima M Oncology; 2010; 79(1-2):136-43. PubMed ID: 21150228 [TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin hypersensitivity: case report and successful repeat desensitization. Edmondson DA; Gruling BJ; Urmanski AM; Wong SJ; Levy MB Am J Ther; 2007; 14(1):116-8. PubMed ID: 17303980 [TBL] [Abstract][Full Text] [Related]
20. Successful desensitization to oxaliplatin. Mis L; Fernando NH; Hurwitz HI; Morse MA Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]